Clinical Scorecard: Impact of Bariatric Surgery on Hormonal Profiles and Ovarian Structure in Women: A Prospective Analysis

At a Glance

Key Highlights

• Bariatric surgery improves ovarian and adrenal hormone profiles, reducing PCOS symptoms and enhancing fertility.
• Postoperative hormonal changes include decreased insulin resistance, lower androgen levels, and regulated ovulation.
• Weight loss after bariatric surgery correlates with improved menstrual regularity, spontaneous conception rates, and pregnancy outcomes.

Guideline-Based Recommendations

Diagnosis

• Assess hormonal profiles including FSH, LH, SHBG, total testosterone, androstenedione, DHEA-S, and AMH preoperatively and postoperatively.
• Evaluate ovarian morphology via ultrasound for polycystic ovary features (string of pearls sign, multiple uniform follicles).
• Use Ferriman-Gallwey score for hirsutism and numeric rating scale for dysmenorrhea severity.

Management

• Consider bariatric surgery (Roux-en-Y gastric bypass or sleeve gastrectomy) for women with BMI ≥35 and obesity-related reproductive dysfunction.
• Exclude patients using hormonal contraceptives or with prior ovarian surgery to avoid confounding hormonal assessments.
• Monitor and manage comorbidities such as diabetes, hypothyroidism, asthma, and hypertension pre- and postoperatively.

Monitoring & Follow-up

• Perform hormonal assessments at baseline, 3 months, and 6 months post-surgery to track changes.
• Conduct gynecological examinations at each time point to evaluate clinical and morphological ovarian changes.
• Use validated scoring systems for symptom severity monitoring (Ferriman-Gallwey, numeric pain rating).

Risks

• Potential variability in long-term hormonal outcomes based on individual patient characteristics.
• Need for ongoing research to clarify complex hormonal effects post-bariatric surgery.

Patient & Prescribing Data

Women aged 18-49 years with BMI ≥35 undergoing robotic bariatric surgery

Majority underwent Roux-en-Y gastric bypass (76.7%) or sleeve gastrectomy (23.9%), with significant hormonal and reproductive improvements observed within 6 months postoperatively

Clinical Best Practices

• Exclude patients on hormonal contraceptives or with prior ovarian surgery for accurate hormonal evaluation.
• Use a multidisciplinary approach involving surgery, endocrinology, and gynecology for comprehensive care.
• Apply standardized hormonal and clinical assessment protocols pre- and post-bariatric surgery.
• Educate patients on expected hormonal and reproductive benefits following bariatric surgery.
• Monitor comorbid conditions closely to optimize overall patient outcomes.

References

• Obesity and hormonal imbalances in reproductive-age women
• Role of ovarian and adrenal hormones in metabolism and reproduction
• Mechanisms of metabolic improvement after bariatric surgery
• Systematic reviews on bariatric surgery and fertility outcomes
• Meta-analyses on pregnancy outcomes post-bariatric surgery
• Babarinsa et al. on bariatric surgery effects on fertility and sexuality
• Postoperative hormonal changes and PCOS symptom improvement
• Ferriman-Gallwey scoring and numeric rating scale for symptom assessment